GinnaG.(Gastillo)LaportMD

Oncology • South San Francisco, CA

Hematologic Oncology

Vice President, Global Head of NHL/CLL Clinical Development Genentech/Roche

Join to view full profile

Dr. Laport is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Laport's full profile

Already have an account?

Office
Genentech/Roche
One DNA Way
South San Francisco, CA 94080
Phone+1 650-387-7276
Is this information wrong?

Education & Training

University of ChicagoFellowship, Hematology and Medical Oncology, 1994 - 1997
Stanford Health Care-Sponsored Stanford UniversityFellowship, Hematology, 1993 - 1994
University of ChicagoResidency, Internal Medicine, 1990 - 1993
McGovern Medical School at UTHealthClass of 1990
Baylor UniversityBA, Psychology, 1982 - 1986

Certifications & Licensure

CA State Medical License 1993 - 2024

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

Autologous or Donor Stem Cell Transplantation in Treating Patients With Recurrent Non-Hodgkin's Lymphoma (BMT CTN 0202) Start of enrollment: 2004 Aug 01
Terminated
Phase 2, Phase 3
Allogeneic Transplantation for Patients With Acute Leukemia or Chronic Myelogenous Leukemia (CML) Start of enrollment: 2002 May 01
Terminated
Haploid Allogeneic Transplant Using the CliniMACS System Start of enrollment: 2001 Nov 01
Terminated
Phase 2
Non-Myeloablative Allogeneic Transplant for Myelodysplastic Syndromes and Myeloproliferative Disorders Start of enrollment: 2001 Dec 01
Completed
Not Applicable
High Dose Chemotherapy and Autologous Transplant for Breast Cancer
Unknown status
Phase 2
CD34 Selection of the Peripheral Blood Stem Cell Graft for Autologous Transplant Start of enrollment: 1996 Sep 01
Completed
Phase 1, Phase 2
Autologous Followed by Non-myeloablative Allogeneic Transplantation for Non-Hodgkin's Lymphoma Start of enrollment: 2007 Jan 01
Terminated
Phase 2
Ph II of Non-myeloablative Allogeneic Transplantation Using TLI & ATG In Patients w/ Cutaneous T Cell Lymphoma Start of enrollment: 2009 May 01
Completed
Phase 2
Blood Stem Cell Transplant With Low Dose Chemotherapy for Relapsed Follicular Non-Hodgkin's Lymphoma (BMT CTN 0701) Start of enrollment: 2009 Apr 01
Completed
Phase 2
Haploidentical Allogeneic Transplant With Post-transplant Infusion of Regulatory T-cells Start of enrollment: 2009 Jun 01
Terminated
Phase 1, Phase 2
Stem Cell Transplant With Lenalidomide Maintenance in Patients With Multiple Myeloma (BMT CTN 0702) Start of enrollment: 2010 May 01
Completed
Phase 3
Social Adaptation in Long Term Survivors of Blood and Marrow Transplantation Start of enrollment: 2009 Nov 01
Completed
Post T-plant Infusion of Allogeneic Cytokine Induced Killer (CIK) Cells as Consolidative Therapy in Myelodysplastic Syndromes/Myeloproliferative Disorders Start of enrollment: 2011 Mar 01
Completed
Phase 2
Phase 1 Infused Donor T Regulatory Cells in Steroid Dependent/Refractory Chronic GVHD Start of enrollment: 2013 Jul 01
Completed
Phase 1
Join now to see all

Publications & Presentations

PubMed

20 citations
Autologous tumor cell vaccine induces antitumor T cell immune responses in patients with mantle cell lymphoma: A phase I/II trial.
Matthew J. Frank, Michael S. Khodadoust, Debra K. Czerwinski, Ole Audun Werner Haabeth, Michael P. Chu, David B. Miklos, Ranjana H. Advani, Ash A. Alizadeh, Neel K. Gu...> ;The Journal of Experimental Medicine. 2020 Sep 7
130 citations
Adenosine 2A Receptor Blockade as an Immunotherapy for Treatment-Refractory Renal Cell Cancer
Lawrence Fong, Andrew Hotson, John D. Powderly, Mario Sznol, Rebecca S. Heist, Toni K. Choueiri, Saby George, Brett G.M. Hughes, Matthew D. Hellmann, Dale R. Shepard, ...> ;Cancer Discovery. 2020 Jan 1
14 citations
Donor-Derived Cytokine-Induced Killer Cell Infusion as Consolidation after Nonmyeloablative Allogeneic Transplantation for Myeloid Neoplasms.
Rupa Narayan, Jonathan Benjamin, Omid Shah, Lu Tian, Keri Tate, Randall Armstrong, Bryan J. Xie, Robert Lowsky, Ginna G. Laport, Robert S. Negrin, Everett Meyer> ;Biology of Blood and Marrow Transplantation. 2019 Jul 1
37 citations
Transplantation of donor grafts with defined ratio of conventional and regulatory T cells in HLA-matched recipients
Everett Meyer, Ginna G. Laport, Bryan J. Xie, Kate MacDonald, Kartoosh Heydari, Bita Sahaf, Sai-Wen Tang, Jeanette Baker, Randall Armstrong, Keri Tate, Cynthia Tadisco...> ;JCI Insight. 2019 May 16
2 citations
Long-term implications of autologous HCT for caregiver quality of life: how does the survivor's health matter?
Irena Stepanikova, Karen Powroznik, Karen S. Cook, D. Kathryn Tierney, Ginna G. Laport> ;Supportive Care in Cancer. 2019 Jan 1
26 citations
Infusion of donor-derived CD8+ memory T cells for relapse following allogeneic hematopoietic cell transplantation.
Lori Muffly, Kevin Sheehan, Randall Armstrong, Kent P. Jensen, Keri Tate, Andrew R. Rezvani, David B. Miklos, Sally Arai, Judith A. Shizuru, Laura Johnston, Everett Me...> ;Blood Advances. 2018 Mar 27
10 citations
Tandem Autologous Hematopoietic Cell Transplantation for Patients with Primary Progressive or Recurrent Hodgkin Lymphoma: A SWOG and Blood and Marrow Transplant Clinic...
Eileen P. Smith, Hongli Li, Jonathan W. Friedberg, Louis S. Constine, Lisa M. Rimsza, James R. Cook, Ginna G. Laport, Leslie Popplewell, Leona Holmberg, Sonali M. Smit...> ;Biology of Blood and Marrow Transplantation. 2017 Dec 28
8 citations
HLA-mismatched unrelated donor transplantation using TLI-ATG conditioning has a low risk of GVHD and potent antitumor activity.
Michael A. Spinner, Marcelo Fernandez-Vina, Lisa E. Creary, Olivia Quinn, Linda Elder, Sally Arai, Laura Johnston, Everett Meyer, David B. Miklos, Lori Muffly, Robert ...> ;Blood Advances. 2017 Jul 25
3 citations
Long-term implications of cancer for work and financial wellbeing: Evidence from autologous hematopoietic cell transplantation (HCT) survivors.
Irena Stepanikova, Karen Powroznik, Karen S. Cook, D. Kathryn Tierney, Ginna G. Laport> ;Maturitas. 2017 Jul 8
10 citations
CD25 Blockade Delays Regulatory T Cell Reconstitution and Does Not Prevent Graft-versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation
Frederick L. Locke, Joseph Pidala, Barry E. Storer, Paul J. Martin, Michael A. Pulsipher, Thomas R. Chauncey, Niels Jacobsen, Nicolaus Kröger, Irwin Walker, Susan Ligh...> ;Biology of Blood and Marrow Transplantation. 2017 Mar 1
37 citations
Reduced-Intensity Conditioning with Fludarabine, Cyclophosphamide, and High-Dose Rituximab for Allogeneic Hematopoietic Cell Transplantation for Follicular Lymphoma: A...
Ginna G. Laport, Juan Wu, Brent R. Logan, Veronika Bachanova, Chitra Hosing, Timothy S. Fenske, Walter L. Longo, Steven M. Devine, Auayporn Nademanee, Iris D. Gersten,...> ;Biology of Blood and Marrow Transplantation. 2016 Aug 1
6 citations
Asia-Pacific Hematology Consortium Report on approach to multiple myeloma. Survey results from the 6th International Hematologic Malignancies Conference: Bridging the ...
Jin Lu, J. Hou, Kai Yan Liu, Simrit Parmar, Adolfo de la Fuente, Borje S. Andersson, Chen Hua Yan, Daobin Zhou, Daryl Tan, David Ritchie, Deipei Wu, Elizabeth J. Shpal...> ;Leukemia & Lymphoma. 2016 Feb 17
44 citations
Reduced-Intensity Allografting as First Transplantation Approach in Relapsed/Refractory Grades One and Two Follicular Lymphoma Provides Improved Outcomes in Long-Term ...
Evgeny Klyuchnikov, Ulrike Bacher, Nicolaus Kröger, Parameswaran Hari, Kwang Woo Ahn, Jeanette Carreras, Veronika Bachanova, Asad Bashey, Jonathon B. Cohen, Anita D'So...> ;Biology of Blood and Marrow Transplantation. 2015 Dec 1
18 citations
Exploring long-term cancer survivors' experiences in the career and financial domains: Interviews with hematopoietic stem cell transplantation recipients
Irena Stepanikova, Karen Powroznik, Karen S. Cook, D. Kathryn Tierney, Ginna G. Laport> ;Journal of Psychosocial Oncology. 2016 Jan 15
26 citations
Long-term sustained disease control in patients with mantle cell lymphoma with or without active disease after treatment with allogeneic hematopoietic cell transplanta...
Jennifer E. Vaughn, Mohamed L. Sorror, Barry E. Storer, Thomas R. Chauncey, Michael A. Pulsipher, Richard T. Maziarz, Michael B. Maris, Parameswaran Hari, Ginna G. Lap...> ;Cancer. 2015 Oct 15
31 citations
Impact of Pretransplantation 18F-fluorodeoxy Glucose–Positron Emission Tomography Status on Outcomes after Allogeneic Hematopoietic Cell Transplantation for Non-Hodgki...
Veronika Bachanova, Linda J. Burns, Kwang Woo Ahn, Ginna G. Laport, Gorgun Akpek, Mohamed A. Kharfan-Dabaja, Taiga Nishihori, Edward Agura, Philippe Armand, Samantha J...> ;Biology of Blood and Marrow Transplantation. 2015 Sep 1
8 citations
Allogeneic hematopoietic cell transplantation after failed autologous transplant for lymphoma using TLI and anti-thymocyte globulin conditioning.
Andrew R. Rezvani, Abraham S. Kanate, Bradley Efron, Saurabh Chhabra, Holbrook E Kohrt, Judith A. Shizuru, Ginna G. Laport, David B. Miklos, Jonathan Benjamin, Laura J...> ;Bone Marrow Transplantation. 2015 Jul 6
4 citations
Recent progress: hematopoietic cell transplant for diffuse large B-cell lymphoma.
Umar Farooq, Ginna G. Laport> ;Leukemia & Lymphoma. 2015 Jul 1
56 citations
Role of Cytotoxic Therapy with Hematopoietic Cell Transplantation in the Treatment of Hodgkin Lymphoma: Guidelines from the American Society for Blood and Marrow Trans...
Miguel-Angel Perales, Izaskun Ceberio, Philippe Armand, Linda J. Burns, Robert T. Chen, Peter D. Cole, Andrew M. Evens, Ginna G. Laport, Craig H. Moskowitz, Uday R. Po...> ;Biology of Blood and Marrow Transplantation. 2015 Jun 1
1 citations
Allogeneic hematopoietic cell transplant for normal karyotype AML: indirect evidence of selection for adverse molecular profile
Mary-Elizabeth M. Percival, Bruno C. Medeiros, Lu Tian, Sarah Robeson, Ginna G. Laport, Laura Johnston, Judith A. Shizuru, David B. Miklos, Sally Arai, Wen-Kai Weng, R...> ;Bone Marrow Transplantation. 2015 Apr 20
17 citations
Blood and Marrow Transplant Clinical Trials Network State of the Science Symposium 2014
Frederick R. Appelbaum, Claudio Anasetti, Joseph H. Antin, Harold L. Atkins, Stella M. Davies, Steven M. Devine, Sergio Giralt, Helen E. Heslop, Ginna G. Laport, Steph...> ;Biology of Blood and Marrow Transplantation. 2015 Feb 1
30 citations
Alternative donors extend transplantation for patients with lymphoma who lack an HLA matched donor
Veronika Bachanova, Linda J. Burns, Tao Wang, Jeanette Carreras, Robert Peter Gale, Peter H. Wiernik, Karen K. Ballen, Baldeep Wirk, Reinhold Munker, David A. Rizzieri...> ;Bone Marrow Transplantation. 2015 Feb 1
63 citations
Recommendations for Donor Human Leukocyte Antigen Assessment and Matching for Allogeneic Stem Cell Transplantation: Consensus Opinion of the Blood and Marrow Transplan...
C. Alan Howard, Marcelo Fernandez-Vina, Frederick R. Appelbaum, Dennis L. Confer, Steven M. Devine, Mary M. Horowitz, Adam Mendizabal, Ginna G. Laport, Marcelo C. Pasq...> ;Biology of Blood and Marrow Transplantation. 2015 Jan 1
58 citations
Significant Improvement in Survival after Unrelated Donor Hematopoietic Cell Transplantation in the Recent Era
Navneet S. Majhail, Pintip Chitphakdithai, Brent R. Logan, Roberta King, Steven M. Devine, Susan N. Rossmann, Gregory A. Hale, Robert J. Hartzman, Chatchada Karanes, G...> ;Biology of Blood and Marrow Transplantation. 2015 Jan 1
68 citations
Allogeneic hematopoietic cell transplantation for mycosis fungoides and Sezary syndrome.
Mary Jo Lechowicz, Hillard M. Lazarus, Jeanette Carreras, Ginna G. Laport, Corey Cutler, Peter H. Wiernik, Gregory A. Hale, Dipnarine Maharaj, Robert Peter Gale, Phill...> ;Bone Marrow Transplantation. 2014 Nov 13
Join now to see all

Lectures

Phase 1/1b multicenter trial of TPST-1120, a peroxisome proliferator-activated receptor alpha (PPARα) antagonist as a single agent (SA) or in combination in patients w...
ASCO Annual Meeting 2019 - Chicago, IL - 6/1/2019
Industry Careers
61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
2012 Highlights of ASH in North America (Las Vegas, NV)
American Society of Hematology (ASH), Las Vegas, Nevada - 1/27/2012

Press Mentions

Epkinly (Epcoritamab) Approved as First Bispecific Antibody for Most Common Non-Hodgkin’s LymphomaMay 25th, 2023
Interview About New Follicular Lymphoma Drug Lunsumio with Genentech’s Dr. Ginna LaportFebruary 24th, 2023
Tempest Therapeutics Starts Phase I/Ib Clinical Trial with First-in-Class PPAR Alpha AntagonistMay 16th, 2019
Join now to see all